Get the Stockscreener App
0.3674
0.52%
0.0019
Glucotrack Inc stock is traded at $0.3674, with a volume of 573.55K.
It is up +0.52% in the last 24 hours and down -30.56% over the past month.
GlucoTrack Inc is a medical device company focused on the development of an implantable continuous blood glucose monitor (CBGM) for patients with Type 1 and Type 2 diabetes. The company is developing its Glucotrack CBGM system to provide continuous glucose monitoring using implantable sensor technology and is advancing the product through clinical studies and regulatory processes.
See More
Previous Close:
$0.3655
Open:
$0.367
24h Volume:
573.55K
Relative Volume:
0.07
Market Cap:
$2.84M
Revenue:
-
Net Income/Loss:
$-16.89M
P/E Ratio:
-0.0176
EPS:
-20.8847
Net Cash Flow:
$-16.44M
1W Performance:
-14.99%
1M Performance:
-30.56%
6M Performance:
-77.73%
1Y Performance:
-93.58%
1-Day Range:
$0.365
$0.389
1-Week Range:
$0.36
$0.4364
52-Week Range:
$0.25
$14.14
Glucotrack Inc Stock (GCTK) Company Profile
Name
Glucotrack Inc
Sector
Industry
Phone
972 (8) 675-7878
Address
301 RT 17 NORTH, RUTHERFORD
Compare GCTK vs ISRG, BDX, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
0.3674 | 2.91M | 0 | -16.89M | -16.44M | -20.88 |
ISRG
Intuitive Surgical Inc
|
394.51 | 141.76B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.40 | 50.00B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
74.25 | 35.57B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
224.46 | 32.78B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
35.74 | 31.15B | 29.14B | 1.07B | 1.05B | 1.1956 |
Glucotrack Inc Stock (GCTK) Latest News
Glucotrack Inc. (GCTK) narrows loss, warns on going concern and closes Lokahi deal - Stock Titan
GlucoTrack Inc (GCTK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GlucoTrack Amends Equity Financing and Issues Commitment Shares - TipRanks
GlucoTrack Inc (GCTK) Stock News Today - TradingKey
GlucoTrack Secures New Financing to Support Growth - The Globe and Mail
Glucotrack Raises $5.5M as It Settles Into Its New Identity as an AI-Driven Biopharma Platform - biobuzz.io
E.F. Hutton Advises on $5.5 Million Financing for Glucotrack Subsidiary Lōkahi Therapeutics - citybiz
E.F. Hutton & Co. Acts as Exclusive Financial Advisor for $5.5 Million Financing for Glucotrack - The Manila Times
Glucotrack Secures $5.5 Million Financing With Premium Equity and Institutional Investment to Boost Growth - Minichart
Glucotrack Raises $5.5 Million Through Bridge Follow-On and Interim PIPE, Adds Registration Rights - TradingView
GlucoTrack, Inc. announced that it expects to receive $5.5 million in funding - marketscreener.com
Glucotrack Secures $5.5 Million Financing to Support Growth Strategy and Product Development - citybiz
Glucotrack Announces $5.5 Million Financing - marketscreener.com
Lōkahi Therapeutics Ai2 Futures Lab Changes How Biopharma Builds a Pipeline - 富途牛牛
Lōkahi Therapeutics™ ai² Futures Lab™ Changes How Biopharma Builds a Pipeline - marketscreener.com
GlucoTrack announces special shareholder meeting - Bitget
GlucoTrack (GCTK) Stock Surges Over 70% After Hours: Why is it Moving? - webull.com
GlucoTrack surges as traders revisit Lōkahi merger and new financing package - quiverquant.com
GlucoTrack, Inc. (NASDAQ:GCTK) surges 95% after LT-100 news, market eyes dilution impact - TechStock²
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
GlucoTrack Advances LT-100 to Single-Injection Development Strategy - TipRanks
Glucotrack (NASDAQ: GCTK) revises $900,000 debt-for-stock deal - Stock Titan
Lōkahi Therapeutics™ Advances LT-100 Development Strategy Toward Single-Injection Administration - Yahoo Finance
GlucoTrack Restructures Debt Through Equity-Linked Note Exchange - theglobeandmail.com
GlucoTrack Creates $900,000 Partitioned Note, Enables Exchanges Into Stock at Market-Based Price - TradingView
Glucotrack (NASDAQ: GCTK) creates $900,000 exchangeable note for stock - Stock Titan
GlucoTrack Inc (GCTK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
GlucoTrack Inc (GCTK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GlucoTrack Inc (GCTK) Income Statement - TradingKey
GCTK Stock Is Soaring Today — What Is Fueling The Surge? - Stocktwits
GlucoTrack Inc (GCTK) Valuation: PE, PB & Fair Value Analysis - TradingKey
TradingKey - TradingKey
GlucoTrack Inc (GCTK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
GlucoTrack Inc (NASDAQ: GCTK) Stock Price, News & Analysis - Kalkine
GCTK|GlucoTrack Inc|Price:0.297|Chg%:+0.006 - TradingKey
GCTK|GlucoTrack Inc|Price:0.294|Chg%:+0.003 - TradingKey
GlucoTrack Inc (GCTK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GCTK|GlucoTrack Inc|Price:0.291|Chg%:-0.021 - TradingKey
GCTK|GlucoTrack Inc|Price:0.313|Chg%:+0.007 - TradingKey
GlucoTrack Inc (GCTK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
GlucoTrack (GCTK) stock rallies 16% after hours: Here's what is going on - MSN
Why Eva Live Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket - Sahm
GlucoTrack Inc. (GCTK) Holds Near Key Support After Modest DeclineDemand Zone - dars.gov.et
GlucoTrack Inc. (GCTK) Slips Slightly Amid Consolidation Near Key SupportVolume Spike Alerts - dars.gov.et
Press Release: Glucotrack, Inc. and Lōkahi Therapeutics(TM) Announce Strategic Financing Support From E.F. Hutton & Co. in Connection With Their Recently Completed Business Combination and Future Capital Markets Initiatives - Moomoo
Glucotrack completes bridge financing after merger - Investing.com UK
Glucotrack completes bridge financing after merger By Investing.com - Investing.com South Africa
Glucotrack, Inc. (NASDAQ: GCTK) sets 2026 vote on reverse split and warrants - Stock Titan
E.F. Hutton & Co. Serves as Exclusive Financial Advisor on Strategic Business Combination Between Glucotrack and Lōkahi Therapeutics and Exclusive Placement Agent for Approximately $5.7 Million Convertible Note Financing - The Manila Times
E.F. Hutton & Co. Serves as Exclusive Financial Advisor on - GlobeNewswire
Glucotrack Gains Slightly on Bridge Financing Deal - Baystreet.ca
Glucotrack Inc Stock (GCTK) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.90%
1.18%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):